US FDA's drug safety office given "equal voice"
This article was originally published in Scrip
Executive Summary
A US FDAmemorandum of agreement bolsters the role of the office of surveillance and epidemiology (OSE) by giving it "equal weight" to the new drugs office (OND) in resolving significant safety issues.